Epidemiology of HIV and viral hepatitis in European countries- Marharyta Shylava

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Treatment issues --- Hepatitis-HIV co-infection- Zahedul Islam

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Management of COVID-19- Akaki Abutidze

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Acute hepatitis- Lali Sharvadze

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

HIV & COVID-19 Coinfection- Prof. Anca Streinu-Cercel

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Liver Disease and COVID-19 Coinfection- Prof. Cihan Yurdaydin

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

SARS-COV-2 Vaccines: a Critical Review- Dr. Kathryn Stephenson

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Update on COVID - 19 Therapeutics- Dr. Daniel Kuritzkes

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

HIV Prevention in High Risk Populations: Unique Challenges and Solutions- Dr. Jean-Michel Molina

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Long-Acting Therapy for PrEP: How Will We Use it?- Mr. Luis Mendão

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Update on Guidelines for Preventing MTCT of Hep B- Dr. Philippa Easterbrook

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Update on the Use of Generic Drugs for HIV in Europe- Ms. Liudmyla Maistat

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Implementation of Integrase Inhibitors for First Line Therapy in the CEE Region: How Far Are We?- Prof. Milosz Parczewski

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

EASL Guidelines on Viral Hepatitis Elimination- Prof. Mojca Matičič

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

The Georgian Model for Hepatitis C Elimination (With Reflection on the Impact of COVID-19 Pandemic)- Prof. Nicole Seguy

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

SARS-CoV-2 antibody seroprevalence in previously undiagnosed persons in Tbilisi, Georgia: Results of three repeated serosurveys

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Rate of HCV reinfection among people living with HCV following successful DAA therapy in Tbilisi, Georgia

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

COVID-19 Challenges and Scale-up in Access to Community-based HCV Treatment for HIV/HCV Co-infected PWIDs in Ukraine

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Dynamics and peculiarities of AIDS mortality in Minsk, Belarus

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

“Evaluate potential impact of COVID-19 pandemic on HIV testing and care national program in the republic of Georgia”

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Effect of remdesivir on mortality in patients with COVID-19: A retrospective cohort study

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Integrating viral hepatitis and PrEP services through KP-led clinics in Vietnam: An opportunity to achieve dual elimination of HIV and viral hepatitis by 2030

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Prevalence of undiagnosed HBV infection in patients with COVID-19

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Obstetric complications in HIV-positive pregnant women, depending on the level of HIV RNA and CD4 count

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021